Cancer

INDICATION: Chronic lymphocytic leukemia (CLL)

Patient sample, cell culture and mouse studies suggest inhibiting IL23P19-IL-23 receptor signaling could help treat CLL. In peripheral blood

Read the full 243 word article

How to gain access

Continue reading with a
two-week free trial.